PT  - JOURNAL ARTICLE
AU  - Yanshuo Wang
TI  - Use Crow-AMSAA Method to predict the cases of the Coronavirus 19 in Michigan and U.S.A
AID  - 10.1101/2020.04.03.20052845
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.03.20052845
4099  - http://medrxiv.org/content/early/2020/04/16/2020.04.03.20052845.short
4100  - http://medrxiv.org/content/early/2020/04/16/2020.04.03.20052845.full
AB  - The Crow-AMSAA method is used in engineering reliability world to predict the failures and evaluate the reliability growth. The author intents to use this model in the prediction of the Coronavirus 19 (COVID19) cases by using the daily reported data from Michigan, New York City, U.S.A and other countries. The piece wise Crow-AMSAA (CA) model fits the data very well for the infected cases and deaths at different phases while the COVID19 outbreak starting. The slope β of the Crow-AMSAA line indicates the speed of the transmission or death rate. The traditional epidemiological model is based on the exponential distribution, but the Crow-AMSAA is the Non Homogeneous Poisson Process (NHPP) which can be used to modeling the complex problem like COVID19, especially when the various mitigation strategies such as social distance, isolation and locking down were implemented by the government at different places.Summary This paper is to use piece wise Crow-AMSAA method to fit the COVID19 confirmed cases in Michigan, New York City, U.S.A and other countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSelf fundedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.worldometers.info/coronavirus/country/us/ https://www.clickondetroit.com/news/local/2020/03/20/michigan-covid-19-data-tracking-case-count-cases-by-county-deaths-cases-by-age-tests/ https://www.worldometers.info/coronavirus/country/us/ https://www.clickondetroit.com/news/local/2020/03/20/michigan-covid-19-data-tracking-case-count-cases-by-county-deaths-cases-by-age-tests/